Kathy V.  Turner net worth and biography

Kathy Turner Biography and Net Worth

Ms. Turner has been a Senior Vice President of IDEXX since May 2014 and the Chief Marketing Officer of IDEXX since January 2020. Prior to becoming the Chief Marketing Officer, she led the company’s Europe, Middle East and Africa (EMEA) Companion Animal Commercial Operations and the company's Asia Pacific Companion Animal, Water, Livestock, Poultry and Dairy Commercial Operations. Prior to joining the company, from 1987 to May 2014, Ms. Turner held various leadership positions with increasing responsibilities at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products and diagnostics. Most recently, Ms. Turner was Divisional Vice President of European Commercial Operations for the Diagnostics Division from 2011 to 2014, and prior to that, Divisional Vice President of Global Strategic Operations for the Diagnostics Division from 2007 to 2011. Ms. Turner holds a bachelor’s degree in marketing and advertising from Syracuse University.

What is Kathy V. Turner's net worth?

The estimated net worth of Kathy V. Turner is at least $3.48 million as of February 14th, 2023. Ms. Turner owns 7,380 shares of IDEXX Laboratories stock worth more than $3,478,489 as of July 25th. This net worth approximation does not reflect any other assets that Ms. Turner may own. Learn More about Kathy V. Turner's net worth.

How do I contact Kathy V. Turner?

The corporate mailing address for Ms. Turner and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected]. Learn More on Kathy V. Turner's contact information.

Has Kathy V. Turner been buying or selling shares of IDEXX Laboratories?

Kathy V. Turner has not been actively trading shares of IDEXX Laboratories over the course of the past ninety days. Most recently, Kathy V. Turner sold 2,000 shares of the business's stock in a transaction on Tuesday, February 14th. The shares were sold at an average price of $504.59, for a transaction totalling $1,009,180.00. Following the completion of the sale, the senior vice president now directly owns 7,380 shares of the company's stock, valued at $3,723,874.20. Learn More on Kathy V. Turner's trading history.

Who are IDEXX Laboratories' active insiders?

IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Bruce Claflin (Director), George Fennell (SVP), Rebecca Henderson (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Jonathan Mazelsky (CEO), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), Giovani Twigge (SVP), and Sophie Vandebroek (Director). Learn More on IDEXX Laboratories' active insiders.

Are insiders buying or selling shares of IDEXX Laboratories?

During the last year, insiders at the sold shares 9 times. They sold a total of 114,848 shares worth more than $61,452,099.64. The most recent insider tranaction occured on May, 17th when Director Bruce L Claflin sold 200 shares worth more than $108,160.00. Insiders at IDEXX Laboratories own 2.1% of the company. Learn More about insider trades at IDEXX Laboratories.

Information on this page was last updated on 5/17/2024.

Kathy V. Turner Insider Trading History at IDEXX Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/14/2023Sell2,000$504.59$1,009,180.007,380View SEC Filing Icon  
2/9/2023Sell1,000$505.04$505,040.006,941View SEC Filing Icon  
12/1/2022Sell3,000$436.00$1,308,000.006,923View SEC Filing Icon  
8/30/2021Sell2,250$687.22$1,546,245.00View SEC Filing Icon  
8/27/2021Sell276$678.00$187,128.00View SEC Filing Icon  
5/28/2021Sell2,000$558.44$1,116,880.002,886View SEC Filing Icon  
5/24/2021Sell2,900$546.24$1,584,096.006,866View SEC Filing Icon  
5/20/2021Sell2,000$537.50$1,075,000.00View SEC Filing Icon  
See Full Table

Kathy V. Turner Buying and Selling Activity at IDEXX Laboratories

This chart shows Kathy V Turner's buying and selling at IDEXX Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IDEXX Laboratories Company Overview

IDEXX Laboratories logo
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Read More

Today's Range

Now: $474.94
Low: $470.10
High: $484.23

50 Day Range

MA: $496.49
Low: $468.20
High: $543.45

2 Week Range

Now: $474.94
Low: $372.50
High: $583.39

Volume

372,973 shs

Average Volume

474,786 shs

Market Capitalization

$39.23 billion

P/E Ratio

45.98

Dividend Yield

N/A

Beta

1.32